FINWIRES · TerminalLIVE
FINWIRES

Aurobindo Pharma Posts Marginal Gains in Fiscal Q4 Consolidated Net Profit; Shares Fall 6%

By

Aurobindo Pharma (NSE:AUROPHARMA, BOM:524804) reported a slight increase in its consolidated attributable net profit to 9.21 billion Indian rupees in the fiscal fourth quarter ended March 31, against 9.03 billion rupees a year ago.

Shares of the company fell over 6% in Friday's trade.

Earnings per share inched up to 15.86 rupees compared with the year-ago figure of 15.56 rupees, according to a Thursday filing to the Indian stock exchanges by the pharmaceutical manufacturer.

Revenue from operations in fiscal Q4 increased to 87.5 billion rupees from 83.8 billion rupees a year earlier.

Related Articles

Asia

StanChart Buys Back Shares

Standard Chartered (HKG:2888) repurchased 773,000 shares on Thursday at an average price of 19.33 pounds sterling apiece, according to a Friday filing with the Hong Kong bourse.The British lender plans to cancel the shares, following which it will have about 2.21 billion shares in issue.

$HKG:2888
Asia

Henlius Biotech Doses First Patient in Phase 1 Tumor Trial in China

Shanghai Henlius Biotech (HKG:2696) dosed the first patient in a Phase 1 clinical trial of HLX316 for injection, according to a Friday Hong Kong bourse filing.The trial is studying the effects of the drug in patients with advanced/metastatic solid tumors in Mainland China.

$HKG:2696
Asia

The Hour Glass' Attributable Profit Jumps 39% in Fiscal H2

The Hour Glass' (SGX:AGS) attributable profit to owners surged 39% during the fiscal second half ended March 31 to SG$103.7 million from SG$74.4 million a year earlier, according to a Friday filing with the Singapore Exchange.Earnings per share came in at SG$0.1610 compared with SG$0.1148 in the year-ago period.The luxury watch retailer's revenue jumped 16% year over year to SG$772.8 million from SG$622.6 million.The company recommended a final dividend of SG$0.04 per share and an interim dividend of SG$0.02 per share.

$SGX:AGS